on 22 Feb 2017
Last Applicant/ Owned by
EISAI R&D MANAGEMENT CO. LTD.
No. 6-10, Koishikawa 4-chomeBunkyo-ku, Tokyo
JP
Serial Number
1513962 filed on 4th Feb 2011
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
pharmaceutical preparations for the treatment of the symptoms of parkinson's diseases, epilepsy, migraines, neuropathic pain and multiple sclerosis.CIPO Classification Code
Nice
1513962
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 7 on 22nd Feb 2017 | Abandoned - Subsection 40(3) |
Submitted for opposition 12 on 5th Jul 2016 | Extension of Time |
Submitted for opposition 68 on 25th Feb 2016 | Rep for Service Name Changed |
Submitted for opposition 67 on 25th Feb 2016 | Agent Name Changed |
Submitted for opposition 12 on 6th Jan 2016 | Extension of Time |
Submitted for opposition 12 on 12th Jun 2015 | Extension of Time |
Submitted for opposition 12 on 15th Dec 2014 | Extension of Time |
Submitted for opposition 12 on 16th Jul 2014 | Extension of Time |
Submitted for opposition 12 on 13th Dec 2013 | Extension of Time |
Submitted for opposition 51 on 23rd Mar 2012 | Allowance Notice Sent |